Status: Not yet recruiting
Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)
The goal of this trial is to determine if the addition of the Heart Logic diagnostic alerts to standard of care therapies will lessen hospitalizations and improve quality of life in patients with heart failure.
Participants needed: 135
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Robert PickettUpdated: Feb 17, 2026Locations: 2
Eligibility criteria
Age 18 years or older [+3]
Refuse to give consent [+4]